Dr. Reddy's Laboratories Ltd. News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Dr. Reddy's Laboratories Ltd. authored by Emkay and published by - Trendlyne research reports.
Item: Dr. Reddy's Laboratories Ltd.
Rating: 1
Author: Emkay

Keep track of all breaking news and updates on Dr. Reddy's Laboratories Ltd. from all sources in a single place.

Load latest

Dr. Reddy's Laboratories Ltd.

24 Jan 2025

1269.40

-1.12%

Core US business weakness coming to the fore

Sell: Dr. Reddy's Laboratories Ltd.

Target

Emkay

Adjusted for the milestone payment received from Journey Medical Corp, 3QFY25 EBITDA for Dr Reddy’s was below street/our estimates. The PAT miss was higher on account of lower other income.

Dr. Reddy's Laboratories Ltd. is trading below its 30 day SMA of 1304.9

Dr. Reddy's Laboratories Ltd.

24 Jan 2025

1269.40

-1.12%

Result Update:Dr Reddys Labs

Buy: Dr. Reddy's Laboratories Ltd.

Target

Axis Direct

We maintain our BUY recommendation on the stock.

Dr. Reddy's Laboratories Ltd. is trading below its 30 day SMA of 1304.9

Dr. Reddy's Laboratories Ltd.

24 Jan 2025

1269.40

-1.12%

Dr Reddys Labs (HOLD): NRT business to require huge marketing spend

Hold: Dr. Reddy's Laboratories Ltd.

BOB Capital Markets Ltd.

North America sales missed our estimates and reported US$ 395mn in 3QFY25 vs US$ 445mn in 2QFY25 impacted by gRevlimid

Dr. Reddy's Laboratories Ltd. is trading below its 30 day SMA of 1304.9

Dr. Reddy's Laboratories Ltd.

23 Jan 2025

1269.40

-1.12%

Dr. Reddy's Laboratories Results Earnings Call for Q3FY25

Conference Call with Dr. Reddy's Laboratories Management and Analysts on Q3FY25 Performance and Outlook. Listen to the full earnings transcript.

Dr. Reddy's Laboratories Ltd.

23 Jan 2025

1269.40

-1.12%

to see Rapid results content

Dr. Reddy's Laboratories Ltd.

23 Jan 2025

1269.40

-1.12%

Result

DR.REDDY'S LABORATORIES LTD. - 500124 - Outcome of Board Meeting

BSE India

Dr Reddys Laboratories Ltd has informed BSE that the Board of Directors of the Company, at its meeting held on January 23, 2025, has inter alia approved the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2024.

pdf

Dr. Reddy's Laboratories Ltd.

22 Jan 2025

1269.40

-1.12%

Company Update

DR.REDDY'S LABORATORIES LTD. - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015

BSE India

Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015

pdf

Dr. Reddy's Laboratories Ltd.

20 Jan 2025

1269.40

-1.12%

Dr Reddy's Labs Q3 Preview: Revlimid to dent US sales, profits may rise 12%

Business Standard

Indian pharmaceutical (IT) major, Dr Reddy's Laboratories, is scheduled to deliver its October-December quarterly earnings for the financial year 2024-25 (Q3FY25) on Thursday, January 23, 2025

Dr. Reddy's Laborato.. has an average target of 1321.50 from 8 brokers.

Dr. Reddy's Laboratories Ltd.

20 Jan 2025

1269.40

-1.12%

Dr Reddy Share Price Live blog for 20 Jan 2025

livemint

Dr Reddy Share Price Today Live Updates : Dr Reddy stock price went up today, 20 Jan 2025, by 0.5 %. The stock closed at 1303.3 per share. The stock is currently trading at 1309.85 per share. Investors should monitor Dr Reddy stock price closely in the coming days and weeks to see how it reacts to the news.